# FDA recall D-0365-2024

> **Contract Pharmaceuticals Limited Canada** · Class III · drug recall initiated 2024-02-20.

## Product

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

## Reason for recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

## Distribution

Nationwide in the U.S. and Puerto Rico

## Key facts

- **Recall number:** D-0365-2024
- **Recalling firm:** Contract Pharmaceuticals Limited Canada
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-02-20
- **Report date:** 2024-03-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mississauga, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0365-2024

## Citation

> AI Analytics. FDA recall D-0365-2024. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0365-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*